Interview with University of Modena's Dr. Beatrice Aramini and Reggio Emilia

Name: Interview with University of Modena's Dr. Beatrice Aramini and Reggio Emilia
Uploaded: 2020-02-04
Duration: 6 min 57 s
Description: Interview regarding their article published in Oncotarget Volume 11, Issue 5 titled Overall survival in patients with lung adenocarcinoma harboring “niche” mutations: an observational study

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access, biweekly journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing OncoTarget.

From January 1, 2021 Oncotarget is a biweekly journal that is published on Tuesday.

Request Conference Sponsorship

Oncotarget Videos with Outstanding Authors

University of Modena's Dr. Beatrice Aramini and Reggio Emilia talk about their Publication in the Open-access Bio-medical Journal Oncotarget

Correspondence to - Beatrice Aramini, email: beatrice.aramini@unimore.it

Keywords: somatic mutations, non-small cell lung cancer (NSCLC), lung cancer treatment, overall survival, target therapy

Subscribe to TOC Alerts

Oncotarget Videos with Outstanding Authors

University of Modena's Dr. Beatrice Aramini and Reggio Emilia talk about their Publication in the Open-access Bio-medical Journal Oncotarget